The Games Conclude, The Teamwork Continues! The past few days were filled with thrilling games and memorable moments. From the intensity of throwball, volleyball, badminton, chess, and carrom to the excitement of the CXO cricket match and the men’s cricket final, every event reflected teamwork and passion. 🏐♟️🏸 Cheers from the sidelines added to the energy, culminating in a closing ceremony that honoured not just the winners but the shared spirit of togetherness. 💫 Swipe through to relive the highlights and keep the #1Spirit alive every day! 🥇🏆 #Cohance #EmployeeSportsMeet #TeamSpirit #Sportsmanship #TogetherWeThrive
Cohance Lifesciences
Pharmaceutical Manufacturing
Hyderabad, Telangana 8,469 followers
Accelerating Advantage.
About us
Cohance Lifesciences is a global, merchant API platform. With 8 manufacturing units (including 5 USFDA approved units) and 2 R&D dedicated units, we serve our marquee clients as partner of choice in a range of niche Intermediates, API, Pharmaceutical Formulation intermediates (PFI), Formulations & Speciality chemicals across both Innovator and Generic molecules. We also specialise in highly specialised CRAMS and Clinical research. As a global player, we have presence in 60 countries and have a growing product basket of 80+ molecules backed by robust R&D and Infrastructure.
- Website
-
https://cohance.com/
External link for Cohance Lifesciences
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Hyderabad, Telangana
- Type
- Privately Held
Locations
-
Primary
Galaxy by Aurobindo Realty, Forming part of Sy No 83/1, Hyderabad Knowledge City TSIIC Raidurg, Panmaktha Plot, 1, Hitech City Rd, opp. IKEA
Hyderabad, Telangana 500081, IN
Employees at Cohance Lifesciences
Updates
-
The energy ignited yesterday at #1Spirit - our annual employee sports meet - is just the beginning! From the inaugural moments that set the stage to the thrilling matches in women’s box cricket and men’s cricket, every game has showcased camaraderie, collaboration, and competitive spirit. 💪🎉 And the excitement doesn’t end here. The coming days promise even more action, anticipation, and unforgettable moments as the field comes alive with the spirit of togetherness. 🌟 Stay tuned as we continue to celebrate teamwork, sportsmanship, and the champions among us! 🥇🏅 #Cohance #EmployeeSportsMeet #TeamSpirit #PlayToWin #WorkAndPlay #Sportsmanship #TogetherWeThrive
-
We are pleased to announce that we have received approval for our Mebeverine HCl New DMF from the CDE, China. This marks the 19th approval of the Cohance platform from CDE China. For more information, please contact us at reachus@cohance.com. #CohanceLifesciences #NMPAApproval #MebeverineHCl #Pharma #DMFApproved #API #CDMO #AcceleratingAdvantage
-
Cohance Lifesciences and Suven Pharmaceuticals are pleased to announce our participation in DCAT Week 2025, scheduled from March 17–20 at the InterContinental New York Barclay. This key event brings together the pharmaceutical community to foster collaboration and share ideas. We are looking forward to connecting with industry professionals. If you’d like to meet with our team during DCAT (Drug, Chemical & Associated Technologies Association) Week, please write to reachus@cohance.com. #CohanceLifesciences #dcatweek2025 #dcat #CDMO #CRO #pharmaceuticalindustry #networking #collaboration
-
Cohance wishes you all a very happy Thanksgiving! #CohanceLifesciences #Thanksgiving2024
-
Cohance Lifesciences and Suven Pharmaceuticals are attending CPHI India 2024, from November 26–28 at the India Expo Centre, Delhi NCR. Our team—Surya Prakash, Jaya Pradeep Gottumukkala and Maheswara Rao B.—will be available to discuss possible collaborations. To schedule a meeting, please contact us at reachus@cohance.com. #CPHIIndia #CohanceLifesciences #SuvenPharma #Pharmaceuticals #Networking
-
On World Quality Day, we celebrate Quality’s transformative power. At Cohance & Suven Pharmaceuticals, we’re committed to moving beyond compliance, fostering a mindset that elevates standards and redefines excellence. From Compliance to Performance, we pledge to create lasting impact in every product we deliver. Together, let’s make Quality our legacy! #SuvenPharma #WorldQualityDay2024
-
Wrapping up an exciting World ADC San Diego 2024! Our team proudly represented Cohance Lifesciences and Suven Pharmaceuticals, connecting with industry peers and exploring advancements in Antibody-Drug Conjugates (ADCs). This event reaffirms our commitment to pushing the boundaries in oncology solutions. Thank you to everyone who visited our booth – looking forward to 2025! #CohanceLifesciences #SuvenPharma #WorldADC2024 #InnovativeSolutions #BiotechInnovation #ADC #PharmaEvents #PharmaceuticalIndustry
-
We’re delighted to announce that our New DMF for Aripiprazole has received approval from the NMPA, China! This is our 8th approval for Unit III and the 18th on the Cohance platform, further accelerating our advantage in delivering quality pharmaceutical solutions. For more information, please contact us at reachus@cohance.com. #CohanceLifesciences #Milestone #NMPAApproval #Aripiprazole #Pharma #DMFApproval #API #CDMO #RegulatorySuccess #AcceleratingAdvantage
-
Discover innovative ADC solutions at World ADC San Diego 2024 with Cohance Lifesciences and Suven Pharmaceuticals! Meet our Chief Commercial Officer, Declan Ryan, PhD (Suven Pharma) at Booth #703 for a discussion on transforming your ADC payload strategies. Whether you’re looking to optimize your current project or explore new possibilities, Ryan and our team are here to provide valuable insights. Book a meeting at reachus@cohance.com #CohanceLifesciences #SuvenPharma #WorldADC2024 #ADCInnovation #PharmaceuticalIndustry #PharmaEvents